Rappta Therapeutics
Rappta Therapeutics is a lead-optimization stage biopharmaceutical company.
Rappta Therapeutics has raised €9.0M across 1 funding round from 2 investors, most recently a Series A round in Oct 2020. Based in Helsinki, Finland; founded 2006; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€9.0M
€9,000,000
Funding rounds
1
Investors
2
distinct backers
Active since
2020-10
latest 2020-10
Funding by year
EUR raised per yearRappta Therapeutics — funding by year — interactive chart.
Data table
| Rappta Therapeutics — funding by year | |
|---|---|
| 2020 | €9.0M |
Signals
High confidenceRaise-next likelihood8
base rate 44% for Series A
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-10-13 | Series A | €9.0M | Novartis Venture Fund,Novo Holdings | View deal → |
Investors
2Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Iceye€1.5BFinland · Space
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
Global coverage: FundingData